Summary by Moomoo AI
Arcutis Biotherapeutics, Inc. officer Burnett Patrick is set to sell 100 shares of common stock on 11/15/2024, with an aggregate market value of $1,003. The shares were acquired on 01/12/2024 through a stock option exercise from Arcutis Biotherapeutics, Inc. and paid for in cash. This transaction follows a series of sales over the past three months, totaling 86,295 shares for gross proceeds of $859,506.